UCB S.A.
Belgium
1 November 2017 - 31 October 2018
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for UCB S.A. published between 1 November 2017 - 31 October 2018 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| AC | FC |
|---|---|
| 14 | 5.27 |
Outputs by subject (FC)
| Subject | AC | FC | |
|---|---|---|---|
| Chemistry | 11 | 3.51 | |
| Life Sciences | 3 | 1.61 | |
Top articles by Altmetric score in current window
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
Nature Communications
2018-09-03
Discovery of an MLLT1/3 YEATS Domain Chemical Probe
Angewandte Chemie International Edition
2018-10-05
1 November 2017 - 31 October 2018
International vs. domestic collaboration by FC
- 0% Domestic
- 100% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by FC (0 total)
- UCB S.A., Belgium
- Domestic institution
Top 10 international collaborators by FC (43 total)
- UCB S.A., Belgium
- Foreign institution
-
University of Cambridge, United Kingdom (UK)
(0)
-
University of Leicester, United Kingdom (UK)
(0)
-
Max Planck Society, Germany
(0)
-
University of Oxford, United Kingdom (UK)
(0)
-
Pfizer Inc., United States of America (USA)
(0)
-
Harvard University, United States of America (USA)
(0)
-
Institut Pluridisciplinaire Hubert Curien (IPHC), France
(0)
-
Cardiff & Vale University Health Board, United Kingdom (UK)
(0)
-
Veramed Ltd., United Kingdom (UK)
(0)
-
PTx Solutions Ltd., United Kingdom (UK)
(0)
Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.
Affiliated joint institutions and consortia
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
